Literature DB >> 33354912

Circulating exosomes repair endothelial cell damage by delivering miR-193a-5p.

Chang Cao1,2, Bo Wang1,2, Junnan Tang1,2, Jimin Zhao3, Jiacheng Guo1,2, Qianqian Guo1,2, Xiaoting Yue1,2, Zenglei Zhang1,2, Gangqiong Liu1, Hui Zhang1, Yunzhe Wang1,2, Jinying Zhang1,2.   

Abstract

Circulating exosomes delivering microRNAs are involved in the occurrence and development of cardiovascular diseases. How are the circulating exosomes involved in the repair of endothelial injury in acute myocardial infarction (AMI) convalescence (3-7 days) was still not clear. In this study, circulating exosomes from AMI patients (AMI-Exo) and healthy controls (Normal-Exo) were extracted. In vitro and in vivo, our study showed that circulating exosomes protected endothelial cells (HUVECs) from oxidative stress damage; meanwhile, Normal-Exo showed better protective effects. Through the application of related inhibitors, we found that circulating exosomes shuttled between HUVECs via dynamin. Microarry analysis and qRT-PCR of circulating exosomes showed higher expression of miR-193a-5p in Normal-Exo. Our study showed that miR-193a-5p was the key factor on protecting endothelial cells in vitro and in vivo. Bioinformatics analyses found that activin A receptor type I (ACVR1) was the potential downstream target of miR-193a-5p, which was confirmed by ACVR1 expression and dual-luciferase report. Inhibitor of ACVR1 showed similar protective effects as miR-193a-5p. While overexpression of ACVR1 could attenuate protective effects of miR-193a-5p. To sum up, these findings suggest that circulating exosomes could shuttle between cells through dynamin and deliver miR-193a-5p to protect endothelial cells from oxidative stress damage via ACVR1.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  exosomes; microRNAs; oxidative damage

Year:  2020        PMID: 33354912     DOI: 10.1111/jcmm.16202

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  7 in total

1.  The potential role of circulating exosomes in protecting myocardial injury in acute myocardial infarction via regulating miR-190a-3p/CXCR4/CXCL12 pathway.

Authors:  Chun-Yuan Jiang; Ting-Ting Zhong; Lu-Wen Qiu; Yan-Feng Liu; Hui-Hua Zuo; Xiao-Fei Huang
Journal:  J Bioenerg Biomembr       Date:  2022-07-22       Impact factor: 3.853

2.  Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway.

Authors:  Lu Jiang; Yan Zhang; Linghui Guo; Chaoyang Liu; Pan Wang; Weihong Ren
Journal:  BMC Cancer       Date:  2021-12-02       Impact factor: 4.430

Review 3.  Connecting different heart diseases through intercellular communication.

Authors:  Tania Martins-Marques
Journal:  Biol Open       Date:  2021-09-08       Impact factor: 2.422

4.  Peripheral Serum Exosomes Isolated from Patients with Acute Myocardial Infarction Promote Endothelial Cell Angiogenesis via the miR-126-3p/TSC1/mTORC1/HIF-1α Pathway.

Authors:  Shasha Duan; Chao Wang; Xiangli Xu; Xiaoshan Zhang; Gaofeng Su; You Li; Shuai Fu; Ping Sun; Jiawei Tian
Journal:  Int J Nanomedicine       Date:  2022-04-02

Review 5.  Non-Exosomal and Exosome-Derived miRNAs as Promising Biomarkers in Canine Mammary Cancer.

Authors:  Patrícia Petroušková; Nikola Hudáková; Marcela Maloveská; Filip Humeník; Dasa Cizkova
Journal:  Life (Basel)       Date:  2022-04-01

Review 6.  Exosomes and Exosomal Cargos: A Promising World for Ventricular Remodeling Following Myocardial Infarction.

Authors:  Jiacheng Fang; Yuxuan Zhang; Delong Chen; Yiyue Zheng; Jun Jiang
Journal:  Int J Nanomedicine       Date:  2022-10-04

Review 7.  Potential Applications and Functional Roles of Exosomes in Cardiometabolic Disease.

Authors:  Sergio Ayala-Mar; Belén Rodríguez-Morales; Pedro Chacón-Ponce; José González-Valdez
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.